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YEARLING CALIFORNIA SEA LIONS (ZALOPHUS
CALIFORNIANUS)
Vanessa A. Fravel, D.V.M., William Van Bonn, D.V.M., Frances Gulland, Vet.M.B., M.R.C.V.S., Ph.D.,
Carlos Rios, MLS (ASCP), Andreas Fahlman, Ph.D., James L. Graham, B.S., and Peter J. Havel,
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Abstract: The Marine Mammal Center (TMMC) cares for malnourished California sea lion (CSL) (Zalophus
californianus) pups and yearlings every year. Hypoglycemia is a common consequence of malnutrition in young
CSLs. Administering dextrose during a hypoglycemic crisis is vital to recovery. Traditional veterinary
approaches to treat hypoglycemia pose therapeutic challenges in otariids, as vascular access and catheter
maintenance can be difficult. The current approach to a hypoglycemic episode at TMMC is to administer
dextrose intravenously (IV) by medically trained personnel. Intraperitoneal (IP) dextrose administration is an
attractive alternative to IV administration because volunteer staff with basic training can administer treatment
instead of waiting for trained staff to treat. This study compares the effects of IV, IP, and no dextrose
administration on serum glucose and insulin in clinically healthy, euglycemic CSL yearlings. Three groups of
animals, consisting of five sea lions each, were treated with 500 mg/kg dextrose using one of the following
routes: IV, IP, or no dextrose (control). A jugular catheter was placed, and blood samples were collected at times
0, 5, 15, 30, 60, 120, 180, and 240 min after dextrose administration. IV dextrose administration resulted in an
increase of serum glucose concentrations from a baseline level of approximately 150 mg/dl to a peak of
approximately 350 mg/dl. The resulting hyperglycemia persisted for approximately 2 hr and was associated with
an attenuated plasma insulin response compared with most terrestrial mammals. Intraperitoneal dextrose
administration resulted in increases of serum glucose to approximately 200 mg/dl, which gradually declined to
baseline by 2 hr after dextrose administration. These data suggest that the initial treatment of a hypoglycemic
crisis in young malnourished CSLs can be accomplished with IP dextrose, thus enabling minimally trained
volunteer staff to respond immediately to a crisis. Further studies are needed to determine the most appropriate
long-term treatment.
Key words: California sea lion, dextrose, hypoglycemia, intraperitoneal, marine mammal, and Zalophus
californianus.
INTRODUCTION
Marine mammal rehabilitation centers along
the west coast of the United States care for
hundreds of malnourished California sea lion
(CSL) (Zalophus californianus) yearlings every
year, and the stranding rate has increased over
the last few years (The Marine Mammal Center
[TMMC], pers. comm.).6 One of the common
sequelae to malnutrition in young CSLs is hypo-
glycemia. Clinical signs of hypoglycemia range
from lethargy to seizures. Administering dextrose
during a hypoglycemic crisis is vital to recovery.
Premature removal of dextrose supplementation
can cause a recurrence of severe hypoglycemia
and is often followed by death from hypoglyce-
mia.17 Traditional veterinary approaches to hypo-
glycemia treatment involve the use of intravenous
(IV) or oral dextrose supplementation; however,
otariids pose therapeutic challenges, as vascular
access and catheter maintenance can be difficult.11
Further, neither pinniped milk nor their prey
contain simple sugars. Therefore, adverse side
effects such as diarrhea can often accompany oral
dextrose treatment.4,7 Historical treatment proto-
cols for hypoglycemia at TMMC in Sausalito,
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California, USA, are to administer an IV bolus of
50% dextrose via the subclavian vein. At TMMC,
this vein is only used when the animal is
unconscious, as this vein is accessed with the
animal in ventral–dorsal recumbency. Animals
typically regain consciousness after the dextrose
bolus, but within hours end up in another
hypoglycemic crisis.
The objective of this study is to investigate a
nonvenous method of dextrose administration
that can be used by nonmedical staff with minimal
training to treat young CSLs during a hypoglyce-
mic emergency and to compare with IV dextrose
administration, which is only given by trained
medical staff. To achieve this, serum glucose and
insulin levels were compared in healthy euglyce-
mic yearling CSLs following IV or intraperitoneal
(IP) dextrose administration or no dextrose
administration (control).
MATERIALS AND METHODS
This study was conducted from July 2011
through August 2012 at TMMC and was autho-
rized by a Stranding Agreement with the National
Marine Fisheries Service, under the approval of
The Marine Mammal Center’s Institutional Care
and Use Committee No. 2011:1 and Marine
Mammal Protection Act Permit No. 932-1905/
MA-009526. TMMC is a private, nonprofit orga-
nization located at Fort Cronkhite, Sausalito,
California, USA, that is licensed to recover,
rehabilitate, and release marine mammals. While
undergoing rehabilitation at TMMC, sea lions are
housed outdoors and are given access to closed-
system, ozone-disinfected, salt water pools.
Fifteen, 1-yr-old CSLs, six females and nine
males, were used in the study. The animals
weighed between 22 and 37 kg, and their standard
lengths were between 81 and 124 cm. The sea
lions underwent rehabilitation following strand-
ing due to trauma, abscesses, pneumonia, and/or
malnutrition. On admission to TMMC, the ani-
mals are given a physical examination, and blood
is drawn and used for serum chemistry, using a
Wasserman chemistry analyzer (Alfa Wasser-
mann Diagnostic Technologies, West Caldwell,
New Jersey 07006, USA) for testing and a
complete blood cell count (CBC) using a Vet
ABC machine (SCIL Animal Care Company,
Gurnee, Illinois 60031, USA) for testing. Medical
treatment is then administered depending on the
results of the blood work and physical. The
animals used were successfully rehabilitated over
the course of about 6 wk. Animals were included
in the study based on age classification (yearling)
and clinical health status. Sea lions were deemed
clinically healthy if they competed for food and
haul-out space with conspecifics, were at or above
normal weight, exhibited normal behavior, and
had clinical resolution of disease. As part of
normal veterinary practices at TMMC, each
animal received a physical examination, serum
chemistry, using a Wasserman chemistry analyzer
(Alfa Wassermann Diagnostic Technologies), and
CBC using a Vet ABC machine (SCIL Animal
Care Company) prior to release. To decrease the
amount of stress on each animal, the physical
examination and blood work were completed
within the first 30 min of the study period for
each animal. If the blood work or physical
examination were abnormal, the animal was
removed from the study and continued rehabili-
tation.
The animals were each randomly assigned to
one of three treatment groups: IV dextrose, IP
dextrose, or a group with no dextrose (control) for
comparison (Table 1). These groups were chosen
because IP was determined to be a method of
dextrose delivery that nonveterinary personnel
could administer with minimal training, com-
pared with IV, which is a method of dextrose
delivery in which only highly trained personnel
can administer during a hypoglycemic event
(TMMC, pers. obs.). A dose of 500 mg/kg was
chosen based on small animal emergency hypo-
glycemia treatment guidelines, which advise dex-
trose to be given as a slow IV bolus.11 The 20%
concentration of dextrose given IP was a higher
concentration than what has been previously
published in pinnipeds because the authors want-
ed to use a more concentrated solution to
decrease the volume of fluid that needed to be
administered. The 20% dextrose solution was
chosen because it was used with little side effects
in large animal medicine to rescue hypoglycemic
neonatal lambs, ovis aries, in a field situation.9
All animals in the study were fasted for 12 hr
overnight and then placed in a dry pen with no
Table 1. Description of the three study groups of
healthy yearling California sea lions.
Treatment
group Treatments
Number
animals
1 No dextrose 5
2 2.5 ml/kg of 20% dextrose
administered intraperitoneally
5
3 2 ml/kg 25% dextrose administered
intravenously
5
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access to water. Each animal was examined
physically prior to anesthesia. The animals were
physically restrained to facilitate anesthesia mask
placement and then induced utilizing 5% isoflur-
ane (Henry Schein Animal Health, Dublin, Ohio
43017, USA) in oxygen. The animals were then
intubated and maintained at an average of 1.4%
isoflurane in oxygen. Heart rate, end-tidal CO2,
respiratory rate, and body temperature were
monitored throughout the procedure. Heart rate
was an average of 102 beats/min and end-tidal
CO2 averaged 54 mm Hg for all the animals in all
the groups. All animals spontaneously ventilated
for the duration of the anesthesia period.
Once the animals were under anesthesia, they
were placed in left lateral recumbency to access
the right side of the neck. Each animal’s neck was
shaved along the right jugular furrow to access the
right jugular vein. Alcohol was placed on the skin
to facilitate ultrasound use. A portable GE Logiq
E Vet ultrasound machine (GE Corporate, Fair-
field, Connecticut 06828, USA) utilizing a 12-
MHz linear probe was used to guide placement of
the sampling catheter. Once the jugular vein was
identified, the skin was aseptically prepared using
a 4% chlorhexidine gluconate (Henry Schein
Animal Health) and 70% isopropyl alcohol rinse
(First Priority, Elgin, Illinois 60123, USA). An 18-
ga, 2.75-inch angiocath needle (MILA 1606,
MILA International, Erlanger, Kentucky 41018,
USA) was placed into the right jugular vein to
introduce the guide wire (MILA 1606, MILA
International). The needle was then removed
while the guide wire stayed in place in the jugular
vein. A 16-ga, 5-French 6-inch long single lumen
catheter (MILA 1606, MILA International) was
then introduced into the jugular vein over the
guide wire. Once the catheter was in place, the
guide wire was removed. The catheter was
secured using a Secur-a-catht device (Interrad
Medical, Plymouth, Minnesota 55441, USA) and
one to three skin sutures using a 3-0 polydiox-
anone suture. A heparinized saline solution (100
U heparin/ml solution) was flushed through the
sampling catheter to maintain patency.
The first blood sample taken from the jugular
catheter was used for a time 0 sample for the
study, and a CBC and serum chemistry panel were
performed utilizing the machines described above
to ensure that blood parameters were within
normal limits.6 After the time 0 blood sample
was collected and the CBC and serum chemistry
results were deemed within normal limits, the
dextrose was administered IV or IP or the animal
was given no dextrose. For the IP injection, the
skin and hair were prepped with 20% betadine
spray (Henry Schein Animal Health), saturating
the area. A site 1 inch to the right of the umbilicus
was chosen for the injection because there are
generally only small intestinal loops in this area,
which should push away from the needle when it
is inserted. A 22-ga, 1-inch needle was used and
inserted into the body wall to the hub, and then
the dextrose solution was administered slowly. If
the CBC and serum chemistry results were not
considered normal, the catheter was removed,
and the animal was placed back into rehabilita-
tion.
Blood was collected using the sampling catheter
5, 15, and 30 min after dextrose treatment and
placed into serum separator tubes. The serum
separator tubes were immediately centrifuged
after clot formation at 768 g for 10 min. The
animals were recovered from anesthesia after the
30-min blood sample was collected. The animals
were then manually restrained to obtain blood,
via the catheter, at the 60-, 120-, 180-, and 240-
min time points. The blood was placed into serum
separator tubes and processed as explained above.
After the 240-min blood sample was collected, the
sampling catheter was removed, and firm pressure
was applied to the catheter site for 5 min or until
bleeding stopped. Triple antibiotic ointment was
then applied to the skin wound. No catheter site
complications were encountered.
Serum collected was analyzed immediately for
blood glucose using a Wasserman chemistry
analyzer (Alfa Wassermann Diagnostic Technol-
ogies), and an aliquot was banked at 808C until
analysis for insulin levels was performed at the
University of California at Davis Veterinary
School Molecular Biosciences laboratory. Insulin
concentrations were measured by radioimmu-
noassy (RIA; EMD Millipore, Billerica, Massa-
chusetts 01821, USA). A human insulin RIA was
used for this study, and insulin concentrations in
sea lion serum samples diluted in parallel as
expected, suggesting good cross-reactivity of sea
lion insulin measured with this assay. The inter-
assay coefficient of variation was 8.9%, and the
intra-assay coefficient of variation was 4.3%.
Due to the low sample size, generalized linear
models followed by Tukey multiple comparison
tests were used to compare differences between
groups for the preadministration glucose and
insulin levels between groups, using treatment as
a dependent variable and animal as a random
factor.8 Statistical analysis of repeated-measures
data was performed using R (lme, version 3.1.0,
2014, R Foundation for Statistical Computing,
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Vienna, Austria 1300). The duration the blood
glucose remained significantly above 135 mg/dl
was determined using a t-test of the average
(6SD) blood glucose levels.
RESULTS
Serum glucose concentrations
Baseline fasting serum glucose concentrations
for all euglycemic sea lions averaged approxi-
mately 150 mg/dl (Fig. 1). There were no
statistical differences in baseline fasting serum
glucose between groups. Serum glucose tended to
decrease over time in animals that received no
dextrose. Animals that received IV dextrose
exhibited the largest increases of serum glucose,
increasing from approximately 150 mg/dl to a
mean peak of approximately 350 mg/dl. Thereaf-
ter, serum glucose levels declined steadily, but
remained over 200 mg/dl at 60 min and then
returned close to baseline by 120 min after
administration. In sea lions that received intra-
peritoneal dextrose, serum glucose concentra-
tions increased gradually, from a baseline of
approximately 150 mg/dl, to 200 mg/dl 60 min
after dextrose administration. The serum glucose
then declined and reached baseline at 120 min.
The maximum average blood glucose values after
dextrose administrations were significantly higher
after IV injection (346 6 33 mg/dl at 5 min)
compared with either IP (193 6 10 mg/dl at 60
min) or no dextrose (148 6 13 mg/dl at time 0).
The peak serum glucose levels were delayed for IP
injection compared with IV injection, whereas
there was no increase in the blood glucose levels
in the control animals (Fig. 1).
Serum insulin responses
Mean fasting serum insulin concentrations were
between 5 and 10 lU/ml in the three groups of
animals. Serum insulin did not increase and
tended to decline slightly in the control group
(Fig. 2). Insulin levels increased rapidly within 5
min after IV dextrose administration and peaked
at 18 lU/ml at 60 min after dextrose administra-
tion (Fig. 2). Serum insulin increased slowly after
IP dextrose administration, doubling from 5 to 10
lU/ml at 15 min, increasing to a peak mean of 15
lU/ml at 60 min, and then declining thereafter.
When comparing the three groups, the insulin
levels appeared to increase only when serum
glucose was .160 mg/dl (Fig. 3).
DISCUSSION
In this study, changes in circulating serum
glucose concentrations following no dextrose
administration versus IV and IP dextrose admin-
istration in euglycemic yearling CSLs indicate
that successful initial treatment of hypoglycemic
sea lions can be achieved with both IP and IV
dextrose administration. Although IV dextrose
administration resulted in a faster increase in
blood glucose, IP dextrose increased blood glu-
cose above baseline (100–130 mg/dl) by the 15-
min time point and had the highest increase by 60
Figure 1. Serum glucose levels (mg/dl) in yearling California sea lions for control (C) animals or following
administration of 500 mg/kg dextrose either intraperitoneally or intravenously.
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min after administration. Blood glucose returned
to baseline by 120 min after dextrose administra-
tion for both IP and IV groups; therefore, one
treatment would most likely not last longer than 2
hr in hypoglycemic sea lions. This study was not
intended to determine the optimal long-term
management of hypoglycemia, but to provide
preliminary information regarding the absorption
of dextrose given IP versus IV, which, to the
authors’ knowledge, has not been published
before.
IP injections can pose problems due to the risk
of accidental puncture of viscera and the risk of
sepsis, especially with multiple needle sticks.3 In
this study, dextrose at a 20% concentration was
used to administer the highest concentration of
dextrose in the lowest volume. The authors
decided on this dose based on recommendations
in large animal medicine for hypoglycemia treat-
Figure 2. Serum insulin levels (lU/ml) in yearling California sea lions for control (C) animals or following
administration of 500 mg/kg dextrose either intraperitoneally or intravenously.
Figure 3. Serum insulin (lU/ml) versus glucose (mg/dl) levels in yearling California sea lions in control (C)
and after administration of 500 mg/kg dextrose either intraperitoneally or intravenously.
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ment of neonatal lambs in a field setting.9 In the
short term, there were no signs of abdominal pain
or discomfort following IP administration of
dextrose. This study was unable to determine the
potential long-term effects of IP dextrose admin-
istration in CSLs.
In all three groups, there was a statistically
significant increase in insulin only after serum
glucose concentrations increased to greater than
160 mg/dl, which is attributed to the increases of
serum glucose stimulating ß-cells in the pancre-
atic islets to release insulin. Increases of serum
insulin concentrations measured in this study
were substantially lower than what would have
been expected in most terrestrial monogastric
animals, such as dogs Canis familiaris.5 Further-
more, the stimulation to release insulin once the
serum glucose concentrations increased above
160 mg/dl is also different from most terrestrial
mammals, which are stimulated to produce insu-
lin once concentrations reach .90 mg/dl.10 This
may be due to the fact that marine mammals
principally eat fish and other aquatic prey in the
wild, which are high in protein and fat and low in
carbohydrates. Pinnipeds are not exposed to
simple carbohydrates during their adult lives
(usually only glycogen in the liver and muscle of
their prey), which means they have a lesser need
for an immediate postprandial insulin response to
help utilize ingested sugars.
Weaned elephant seal (Mirounga angustirostris)
pups challenged with an injection of dextrose IV
lacked an insulin response all together, which is
different from what was found in this study with
CSL yearlings. This lack of response is likely due
to an alternate regulation of blood glucose
compared with most terrestrial mammals that
utilize more rapid changes of insulin and glucagon
to maintain circulating glucose homeostasis.
Fasting elephant seals rely on the oxidation of
their fat stores to meet much of their energy
requirements for their peripheral tissues. This
allows glucose to be directed toward glucose-
dependent tissues such as red blood cells and the
brain.2,15 The current study documented an insulin
response to blood glucose concentrations .160
mg/dl, which may indicate that CSLs have more
of a capacity to utilize glucose compared with
elephant seals. This may extend into critical care
of elephant seals in the rehabilitation setting that
may not be able to respond to boluses of IV
dextrose like the CSLs in this study did (TMMC,
pers. obs.). More research is needed to investigate
dextrose treatment for hypoglycemia in elephant
seals.
The results observed in this study are different
than what has been observed in bottlenose
dolphins (Tursiops truncatus). In one study, bot-
tlenose dolphins were challenged with oral dex-
trose, and a sustained hyperglycemia and
insulinemia were seen for 10 hr after administra-
tion.13,14 Dolphins in this study also showed a
sustained hyperglycemia after a protein meal of
mackerel. Dolphins have a larger brain/body
mass ratio compared with pinnipeds, and this
sustained hyperglycemia may be attributed to the
dolphin brain’s high demand for glucose.13,14
This study utilized normoglycemic, well-hy-
drated sea lions; therefore, there may be differ-
ences in the amount of absorption and time it
takes for absorption in the peritoneal space and
vascular space compared with sea lions experi-
encing hypoglycemia and dehydration. Currently
at TMMC, a 20% dextrose IP treatment is being
given to young CSLs during a hypoglycemic
event, and this has successfully resuscitated
animals within 5 min of administration (TMMC,
pers. obs.). This is different compared with the
data presented in the current study, which dem-
onstrates a modest elevation in blood glucose 5
min following dextrose administration. Clinical
response at only 5 min may be attributable to the
animal only requiring a small increase in serum
glucose to regain consciousness, but further
studies are needed to investigate the effects of
IV and IP dextrose therapy on clinically hypogly-
cemic animals. Further studies also need to
investigate electrolyte status and serum glucose
trends to evaluate the full biochemical picture.
Young CSLs that present to TMMC with
malnutrition are placed on a feeding protocol,
which consists of feeding via stomach gavage
three times a day. First, the animals are gavaged
an electrolyte formula without dextrose, and then
they are transitioned over 3 days onto a formula
that contains water, blended herring, and salmon
oil (TMMC, pers. obs.). The sea lions are then
offered freshly thawed herring and are switched to
whole fish once they eat on their own. Refeeding
syndrome occurs during judicial refeeding of
severely malnourished humans. The hallmark
signs are hypophosphatemia accompanied often-
times with hypokalemia and/or hypomagnesae-
mia with pathologic extracellular fluid. When
feeding is recommenced following severe malnu-
trition, a surge of insulin is accompanied by a
marked rise of metabolic rate and contributes to
the electrolyte and vitamin imbalances.16 Refeed-
ing syndrome has not been documented in
pinnipeds but may be a factor in some animals
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that do not respond to the traditional feeding plan
described above. Furthermore, this study showed
that sea lions appear to have an attenuated insulin
response compared with terrestrial animals,
which may prevent them from developing this
syndrome. More research needs to be performed
to truly understand whether refeeding syndrome
exists for pinnipeds and how it may relate to
hypoglycemia treatment.
Traditional treatment at TMMC for acute
hypoglycemia in pups and malnourished yearling
CSLs relied on IV administration of dextrose by
trained veterinary staff. This study suggests that
nonveterinary staff can administer IP dextrose
and get similar results to IV dextrose administra-
tion. Further studies are needed to determine the
clinical efficacy of this short-term treatment and
to develop more effective modalities for long-
term treatment. To the authors’ knowledge, this is
the first publication documenting serum glucose
and insulin changes when yearling CSLs are
challenged with dextrose IP and IV.
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